论文部分内容阅读
目的:探究中医标本同治法配合克罗米芬治疗多囊卵巢综合征性不孕的临床疗效。方法:选取2010年3月~2013年6月在该院进行医治的多囊卵巢综合征性不孕患者96例,将其平均分为两组,每组48例。实验组患者使用中医标本同治法联合克罗米芬进行治疗,对照组患者仅使用克罗米芬进行治疗,均以2个月为1个治疗周期,把两组患者的内分泌激素、排卵时期、妊娠情况以及临床主要表现作为检测指定的标准。结果:实验组患者机体内分泌激素水平明显优于对照组,差异有统计学意义(P<0.05);实验组患者的排卵情况和妊娠率明显高于对照组,差异有统计学意义(P<0.05);实验组患者的总有效率(93.75%)明显高于对照组(62.50%),差异有统计学意义(P<0.05)。结论:将中医标本同治法联合克罗米芬用于治疗多囊卵巢综合征性不孕患者比仅使用克罗米芬治疗的效果好,患者的症状得到明显改善,不良反应较少,在临床上可以广泛运用。
Objective: To investigate the clinical curative effect of Tongzhi method combined with clomiphene for the treatment of polycystic ovary syndrome infertility. Methods: A total of 96 patients with polycystic ovary syndrome infertility who were treated in our hospital from March 2010 to June 2013 were selected and divided into two groups (48 in each group). The patients in the experimental group were treated with traditional Chinese medicine and clomiphene citrate, while those in the control group were only treated with clomiphene. All patients were treated with 2 months as a treatment cycle. The endocrine hormones, ovulation period, pregnancy and clinical The main performance as the test specified standards. Results: The levels of endocrine hormone in the experimental group were significantly better than those in the control group (P <0.05). The ovulation rate and pregnancy rate in the experimental group were significantly higher than those in the control group (P <0.05 ). The total effective rate (93.75%) in the experimental group was significantly higher than that in the control group (62.50%), the difference was statistically significant (P <0.05). Conclusion: The Chinese medicine with Tongzhi law combined with clomiphene in the treatment of women with polycystic ovary syndrome infertility than clomiphene citrate treatment effect is good, the patient’s symptoms have been significantly improved, fewer adverse reactions, can be widely used in clinical practice .